Wistar Institute Of Anatomy & Biology
- Assets
- $402.4m
- Revenue
- $181.3m
- Investments
- $28.7m
- Employees
- 457
- Location
- Philadelphia, PA
- Founding
- 11/1946
- Data as of
- 12/2023
- EIN
- 23-6434390
Organization Overview
Wistar Institute Of Anatomy & Biology is located in Philadelphia, PA. The organization was established in 1946. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. As of 12/2023, Wistar Institute Of Anatomy & Biology employed 457 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Wistar Institute Of Anatomy & Biology is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Wistar Institute Of Anatomy & Biology generated $181.3m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 10.1% each year . All expenses for the organization totaled $91.8m during the year ending 12/2023. While expenses have increased by 6.5% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
BIOMEDICAL RESEARCH WITH SPECIAL EXPERTISE IN CANCER RESEARCH AND VACCINE DEVELOPMENT (IMMUNOLOGY).
Describe the Organization's Program Activity:
THE WISTAR INSTITUTE IS THE NATION'S FIRST INDEPENDENT NONPROFIT INSTITUTION DEVOTED EXCLUSIVELY TO FOUNDATIONAL BIOMEDICAL RESEARCH AND TRAINING. SINCE 1972, THE INSTITUTE HAS HELD NATIONAL CANCER INSTITUTE (NCI)-DESIGNATED CANCER CENTER STATUS. THROUGH A CULTURE AND COMMITMENT TO BIOMEDICAL COLLABORATION AND INNOVATION, WISTAR SCIENCE LEADS TO BREAKTHROUGH EARLY-STAGE DISCOVERIES. WISTAR SCIENTISTS ARE DEDICATED TO SOLVING SOME OF THE WORLD'S MOST CHALLENGING PROBLEMS IN THE FIELD OF CANCER AND IMMUNOLOGY, ADVANCING HUMAN HEALTH THROUGH EARLY-STAGE DISCOVERY AND TRAINING THE NEXT GENERATION OF BIOMEDICAL RESEARCHERS. THE WISTAR INSTITUTE INCLUDES THE ELLEN AND RONALD CAPLAN CANCER CENTER, AND THE VACCINE & IMMUNOTHERAPY CENTER. WISTAR SCIENTISTS BENEFIT FROM THE TECHNOLOGICAL SUPPORT AND STATE-OF-THE-SCIENCE INSTRUMENTATION PROVIDED BY THE INSTITUTE'S SHARED RESOURCES. WISTAR HAS A PROVEN TRACK RECORD OF SUCCESS IN VACCINE DISCOVERY THAT LED TO VACCINES AGAINST RUBELLA, RABIES, AND ROTAVIRUS. WISTAR'S HUBERT J.P. SCHOEMAKER EDUCATION AND TRAINING CENTER HAS LAUNCHED NEW COLLABORATIONS WITH LOCAL AND INTERNATIONAL INSTITUTIONS WITH THE GOAL OF EXPANDING LIFE SCIENCE EDUCATION IN PENNSYLVANIA AND BEYOND. WISTAR HAS A ROBUST RANGE OF STEM-BASED PROGRAMS FOCUSED ON INCREASING ACCESS TO LIFE SCIENCE CAREERS FOR UNDER-REPRESENTED COMMUNITIES INCLUDING NON-TRADITIONAL STUDENTS AND ADULT LEARNERS. WISTAR'S EDUCATION & TRAINING PROGRAMS SUPPORT STEM-BASED, BIOMEDICAL RESEARCH CAREER OPPORTUNITIES FOR HIGH SCHOOL, UNDERGRADUATE, GRADUATE STUDENTS AND POSTDOCTORAL FELLOWS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Richard M Horowitz Trustee - Board Chair | OfficerTrustee | 4 | $0 |
Steven V Abramson Trustee | Trustee | 1 | $0 |
Elizabeth Mckee Anderson Trustee | Trustee | 2 | $0 |
Max Berger Appointed Dec 2023 Trustee | Trustee | 1 | $0 |
Douglas S Briggs Trustee | Trustee | 1 | $0 |
Ira Brind Trustee | Trustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
The Arthur Jackson Company Janitorial Services | 12/30/23 | $907,000 |
Allied Universal Security Services Security Services | 12/30/23 | $708,000 |
Ascendia Pharmaceuticals Inc Development Services | 12/30/23 | $596,000 |
Riverside Law Llp Legal Services | 12/30/23 | $528,000 |
Triumvirate Environmental Inc Environmental Solutions Services | 12/30/23 | $463,000 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $61,320,000 |
| All other contributions, gifts, grants, and similar amounts not included above | $9,416,000 |
| Noncash contributions included in lines 1a–1f | $598,000 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $70,736,000 |
| Total Program Service Revenue | $4,069,000 |
| Investment income | $9,045,000 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $5,346,000 |
| Net Rental Income | $56,000 |
| Net Gain/Loss on Asset Sales | $91,426,000 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $181,250,000 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $2,884,000 |
| Compensation of current officers, directors, key employees. | $1,287,000 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $24,759,000 |
| Pension plan accruals and contributions | $2,147,000 |
| Other employee benefits | $4,348,000 |
| Payroll taxes | $1,717,000 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $1,329,000 |
| Fees for services: Accounting | $215,000 |
| Fees for services: Lobbying | $268,000 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $591,000 |
| Fees for services: Other | $4,360,000 |
| Advertising and promotion | $185,000 |
| Office expenses | $387,000 |
| Information technology | $1,416,000 |
| Royalties | $0 |
| Occupancy | $4,702,000 |
| Travel | $554,000 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $1,323,000 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $7,549,000 |
| Insurance | $298,000 |
| All other expenses | $206,000 |
| Total functional expenses | $91,822,000 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $4,320,000 |
| Savings and temporary cash investments | $11,011,000 |
| Pledges and grants receivable | $24,933,000 |
| Accounts receivable, net | $19,630,000 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $657,000 |
| Prepaid expenses and deferred charges | $4,543,000 |
| Net Land, buildings, and equipment | $91,899,000 |
| Investments—publicly traded securities | $194,682,000 |
| Investments—other securities | $28,747,000 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $21,970,000 |
| Total assets | $402,392,000 |
| Accounts payable and accrued expenses | $16,689,000 |
| Grants payable | $0 |
| Deferred revenue | $10,813,000 |
| Tax-exempt bond liabilities | $52,780,000 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $80,282,000 |
| Net assets without donor restrictions | $224,558,000 |
| Net assets with donor restrictions | $97,552,000 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $402,392,000 |